DRTECH Corporation Total Assets
DRTECH Corporation total assets. Based on the latest financial reports, DRTECH Corporation (214680) holds total assets worth ₩235.84 Billion KRW (≈ $159.82 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see DRTECH Corporation market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of DRTECH Corporation (2016–2025)
Total assets of DRTECH Corporation from 2016 to 2025. This chart illustrates how DRTECH Corporation's total assets have evolved over time, based on quarterly financial data. See DRTECH Corporation (214680) stock price for real-time trading data and today's change.
DRTECH Corporation - Asset Composition Analysis
DRTECH Corporation Total Assets Breakdown (December 2025)
DRTECH Corporation total assets breakdown as of December 2025. DRTECH Corporation's total assets of ₩235.84 Billion consist of 68.3% current assets and 31.7% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 10.5% |
| Accounts Receivable | ₩52.67 Billion | 26.1% |
| Inventory | ₩46.45 Billion | 23.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩1.93 Billion | 1.0% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how DRTECH Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore DRTECH Corporation current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DRTECH Corporation's current assets represent 68.3% of total assets in 2025, a decrease from 73.2% in 2016.
- Cash Position: Cash and equivalents constituted 10.5% of total assets in 2025, up from 2.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 3.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 26.1% of total assets.
DRTECH Corporation Competitors by Total Assets
Key competitors of DRTECH Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
DRTECH Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.94 | 2.15 | 2.86 |
| Quick Ratio | 1.39 | 1.40 | 2.12 |
| Cash Ratio | 0.00 | 0.00 | 0.26 |
| Working Capital | ₩84.82 Billion | ₩69.21 Billion | ₩41.39 Billion |
DRTECH Corporation - Advanced Valuation Insights
This section examines the relationship between DRTECH Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.00 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 12.6% |
| Total Assets | ₩201.88 Billion |
| Market Capitalization | $35.70 Million USD |
Valuation Analysis
Below Book Valuation: The market values DRTECH Corporation's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: DRTECH Corporation's assets grew by 12.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for DRTECH Corporation (2016–2025)
The table below shows the annual total assets of DRTECH Corporation from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩201.88 Billion ≈ $136.81 Million |
+12.56% |
| 2024-12-31 | ₩179.35 Billion ≈ $121.54 Million |
+9.35% |
| 2023-12-31 | ₩164.02 Billion ≈ $111.15 Million |
+35.80% |
| 2022-12-31 | ₩120.78 Billion ≈ $81.85 Million |
+28.63% |
| 2021-12-31 | ₩93.90 Billion ≈ $63.63 Million |
+2.28% |
| 2020-12-31 | ₩91.81 Billion ≈ $62.22 Million |
+29.38% |
| 2019-12-31 | ₩70.96 Billion ≈ $48.09 Million |
+42.49% |
| 2018-12-31 | ₩49.80 Billion ≈ $33.75 Million |
+14.45% |
| 2017-12-31 | ₩43.51 Billion ≈ $29.49 Million |
+15.67% |
| 2016-12-31 | ₩37.62 Billion ≈ $25.49 Million |
-- |
About DRTECH Corporation
DRTECH Corporation develops and sells flat-panel X-ray detectors for digital radiography in South Korea and internationally. Its products include detectors for general radiography, mammography, dynamic, dental, veterinary, and industrial applications; imaging solutions, including specialized UI software, dual energy x-ray imaging, AI imaging processing, advanced image reconstruction technology, a… Read more